Candel Therapeutics Inc.

CADL | NASDAQ

Price Alert Chart Builder DCF Calculator

$11.69

+$0.48 (+4.28%)

Sep 22, 2026, 11:21 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-38.18M	-55.18M	-37.94M	-18.79M	-36.12M	-17.68M
Depreciation & Amortization	845K	990K	960K	778K	232K	91K
Stock-Based Compensation	3.82M	5.31M	3.09M	2.31M	2.96M	2.11M
Other Working Capital	1.39M	531K	-570K	1.28M	-1.55M	1.49M
Other Non-Cash Items	-6.98M	21.51M	169K	-15.78M	76K	4.64M
Deferred Income Tax	n/a	n/a	n/a	n/a	11.51M	n/a
Change in Working Capital	2.19M	346K	-525K	71K	-876K	1.77M
Operating Cash Flow	-38.31M	-27.02M	-34.24M	-31.42M	-22.22M	-9.07M
Capital Expenditures	-587K	-16K	-457K	-1.3M	-1.84M	-1.48M
Cash Acquisitions	27K	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	-6K
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	39.94M
Other Investing Acitivies	n/a	n/a	177K	n/a	n/a	n/a
Investing Cash Flow	-560K	-16K	-280K	-1.3M	-1.84M	38.46M
Debt Repayment	36.21M	-9.17M	n/a	19.91M	n/a	460K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	1.69M	-121K	64K	465K	30K
Financial Cash Flow	56.1M	94.28M	-121K	19.97M	71.8M	490K
Net Cash Flow	17.23M	67.24M	-34.65M	-12.74M	47.75M	29.87M
Free Cash Flow	-38.9M	-27.04M	-34.7M	-32.72M	-24.05M	-10.55M
Adj. Free Cash Flow	-42.72M	-32.35M	-37.79M	-35.02M	-27.02M	-12.65M
Maintenance CapEx	-587K	-16K	-457K	-1.3M	-1.84M	-1.48M
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-38.9M	-27.04M	-34.7M	-32.72M	-24.05M	-10.55M